Ambient tonicity and intestinal cytochrome CYP3A

Bibliography

• Isin EM, Guengerich FP. Substrate binding to cytochromes P450. Anal Bioanal Chem 2008;392:1019-30
   PubMed Web of Science ®Google Scholar
• Lamb DC, Waterman MR, Kelly SL, Guengerich FP. Cytochromes P450 and drug discovery. Curr Opin Biotechnol 2007;18:504-12
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Mechanisms of cytochrome P450 substrate oxidation: minireview. J Biochem Mol Toxicol 2007;21:163-8
   PubMed Web of Science ®Google Scholar
• Pelkonen O, Turpeinen M, Hakkola J, Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol 2008;82:667-715
   PubMed Web of Science ®Google Scholar
• Ma Q, Lu AY. CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies. Drug Metab Dispos 2007;35:1009-16
   PubMed Web of Science ®Google Scholar
• Yamada H, Ishii Y, Yamamoto M, Oguri K. Induction of the hepatic cytochrome P450 2B subfamily by xenobiotics: research history, evolutionary aspect, relation to tumorigenesis and mechanism. Curr Drug Metab 2006;7:397-409
   PubMed Web of Science ®Google Scholar
• Raunio H, Rautio A, Pelkonen O. The CYP2A subfamily: function, expression and genetic polymorphism. IARC Sci Publ 1999;148:197-207
   PubMedGoogle Scholar
• Kessova I, Cederbaum AI. CYP2E1: biochemistry, toxicology, regulation and function in ethanol-induced liver injury. Curr Mol Med 2003;3:509-18
   PubMed Web of Science ®Google Scholar
• Martinez-Jimenez CP, Jover R, Donato MT, Transcriptional regulation and expression of CYP3A4 in hepatocytes. Curr Drug Metab 2007;8:185-94
   PubMed Web of Science ®Google Scholar
• Westlind A, Malmebo S, Johansson I, Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43. Biochem Biophys Res Commun 2001;182:1349-55
   Google Scholar
• Komura H, Iwaki M. Species differences in in vitro and in vivo small intestinal metabolism of CYP3A substrates. J Pharm Sci 2008;97:1775-800
   PubMed Web of Science ®Google Scholar
• Thelen K, Dressman JB. Cytochrome P450-mediated metabolism in the human gut wall. J Pharm Pharmacol 2009;61:541-58
   PubMed Web of Science ®Google Scholar
• Kolars JC, Schmiedlin-Pen P, Schuetz JD, Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 1992;90:1871-8
   PubMed Web of Science ®Google Scholar
• McKinnon RA, Burgess WM, Hall PM, Characterization of CYP3A gene subfamily expression in human gastrointestinal tissues. Gut 1995;36:259-267
   PubMed Web of Science ®Google Scholar
• Stanley LA, Horsburgh BC, Ross J, PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab Rev 2006;38:515-97
   PubMed Web of Science ®Google Scholar
• Kolar JC, Awni WM, Merion RM, Watkins PB. First-pass metabolism of cyclosporine by the gut. Lancet 1991;14:1488-90
   Google Scholar
• Tsunoda SM, Velez RL, Von Moltke LL, Greenblatt DJ. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: Effect of ketoconazole. Clin Pharmacol Ther 1999;66:461-71
   PubMed Web of Science ®Google Scholar
• Holtbecker N, Fromm MF, Kroemer HK, The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism. Drug Metab Dispos 1996;24:1121-3
   PubMed Web of Science ®Google Scholar
• Lown KS, Bailey DG, Fontana RJ, Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal protein expression. J Clin Invest 1997;99:2545-53
   PubMed Web of Science ®Google Scholar
• Fromm MF, Busse D, Kroemer HK, Eichelbaum M. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin. Hepatology 1996;24:796-801
   PubMed Web of Science ®Google Scholar
• Bailey DG, Malcon J, Arnold O, Spence JD. Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998;46:101-10
   PubMed Web of Science ®Google Scholar
• Satsu H, Hiura Y, Mochizuki K, Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals. J Agric Food Chem 2008;56:5366-73
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Gerbal-Chaloin S, Drocourt L, The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 2003;1619:243-53
   PubMed Web of Science ®Google Scholar
• Fukumori S, Murata T, Taguchi M, Hashimoto Y. Rapid and drastic induction of CYP3A4 mRNA expression via vitamin D receptor in human intestinal LS180 cells. Drug Metab Pharmacokinet 2007;22:377-81
   PubMed Web of Science ®Google Scholar
• Wang K, Chen S, Xie W, Wang YJ. Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway. Biochem Pharmacol 2008;75:2204-13
   PubMed Web of Science ®Google Scholar
• Tegude H, Schnabel A, Zanger UM, Molecular mechanism of basal CYP3A regulation by hepatocyte nuclear factor 4alpha: evidence for direct regulation in the intestine. Drug Metab Dispos 2007;35:946-54
   PubMed Web of Science ®Google Scholar
• Sheppard KE. Nuclear receptors. II. Intestinal corticosteroid receptors. Am J Physiol Gastrointest Liver Physiol 2002;282:G742-746
   PubMed Web of Science ®Google Scholar
• Wisely GB, Miller AB, Davis RG, Hepatocytes nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure 2002;10:1225-34
   PubMed Web of Science ®Google Scholar
• Kosuge K, Chuang AI, Uematsu S, Discovery of osmosensitive transcriptional regulation of human cytochrome P450 3As by the tonicity-responsive enhancer binding protein (nuclear factor of activated T cells 5). Mol Pharmacol 2007;72:826-37
   PubMed Web of Science ®Google Scholar
• Go WY, Liu X, Roti MA, NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc Natl Acad Sci USA 2004;101:10673-8
   PubMed Web of Science ®Google Scholar
• Kultz D, Chakravavarty D. Hyperosmolality in the form of elevated NaCl but not urea causes DNA damage in murine kidney cells. Proc Natl Acad Sci USA 2001;98:1999-2004
   PubMed Web of Science ®Google Scholar
• Dmitrieva NI, Cai Q, Burg MB. Cells adapted to high NaCl have many DNA breaks and impaired DNA repair on in cell culture and in vivo. Proc Natl Acad Sci USA 2004;101:2317-22
   PubMed Web of Science ®Google Scholar
• Dmitrieva NI, Michea LF, Burg M. P53 protects renal inner medullary cells from hypertonicity stress by restricting DNA replication. Am J Physiol Renal Physiol 2001;281:F522-30
   PubMed Web of Science ®Google Scholar
• Dmitrieva NI, Michea LF, Rocha GM, Burg M. Cell cycle delay and apoptosis in response to osmotic stress. Comp Biochem Phyisol A Mol Integr Physiol 2001;130:411-20
   PubMed Web of Science ®Google Scholar
• Copp J, Wiley S, Ward MW, Van Der Geer P. Hypertonic shock inhibits growth factor receptor signaling, induces caspase 3 activation and causes reversible fragmentation of the mitochondria network. Am J Physiol Cell Physiol 2005;288:C403-15
   PubMed Web of Science ®Google Scholar
• Di Ciano C, Nie Z, Szaszi K, Osmotic stress-induced remodeling of the cortical cytoskeleton. Am J Physiol Cell Physiol 2002;283:C850-65
   PubMed Web of Science ®Google Scholar
• Morley SJ, Naegele S. Phosphorylation of eukaryotic initiation factor (eIF) 4E is not required for de novo protein synthesis following recovery from hypertonic stress in human kidney cells. J Biol Chem 2002;277:32855-9
   PubMed Web of Science ®Google Scholar
• Zhang Z, Dmitrieva NI, Park HK, High urea and NaCl carbonylate proteins in renal cells in culture and in vivo, and high urea causes 8-oxoguanine lesions in their DNA. Proc Natl Acad Sci USA 2004;101:9491-6
   PubMed Web of Science ®Google Scholar
• Burg MB, Ferrais JD, Dmitrieva NI. Cellular response to hyperosmotic stresses. Physiol Rev 2007;87:1441-74
   PubMed Web of Science ®Google Scholar
• Ho SN. Intracellular water homeostasis and the mammalian cellular osmotic stress response. J Cell Physiol 2006;206:9-15
   PubMed Web of Science ®Google Scholar
• Lang F, Busch GL, Ritter M, Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998;78:247-306
   PubMed Web of Science ®Google Scholar
• Garner MM, Burg MB. Macromolecular crowding and confinement in cells exposed to hypertonicity. Am J Physiol 1994;266:C877-892
   PubMed Web of Science ®Google Scholar
• Street TO, Bolen DW, Rose GD. A molecular mechanism for osmolyte-induced protein stability. Proc Natl Acad Sci USA 2006;103:13997-4002
   PubMed Web of Science ®Google Scholar
• Ko BC, Ruepp B, Bohren KM, Identification and characterization of multiple osmotic response sequence in the human aldose reductase gene. J Biol Chem 1997;272:16431-7
   PubMed Web of Science ®Google Scholar
• Rims JS, Atta MG, Dahl SC, Transcription of the sodium/myo-inositol cotransporter gene is regulated by multiple tonicity-responsive enhancers spread over 50 kilobase pairs in the 5′-flanking region. J Biol Chem 1998;273:20615-21
   PubMed Web of Science ®Google Scholar
• Miyakawa H, Woo SK, Chen CP, Cis- and trans-acting regulating transcription of the BGT1 gene in response to hypertonicity. Am J Physiol 1998;274:F753-761
   PubMed Web of Science ®Google Scholar
• Ito T, Fujio Y, Hirata M, Expression of taurine transporter is regulated through the TonE (tonicity-responsive element)/TonEBP (TonE-binding protein) pathway and contributes to cytoprotection in HepG2 cells. Biochem J 2004;382:177-82
   Google Scholar
• Woo SK, Lee SD, Na KY, TonEBP/NFAT5 stimulates transcription of HSP70 in response to hypertonicity. Mol Cell Biol 2002;22:5753-60
   PubMedGoogle Scholar
• Lopez-Rodriguez C, Aramburu J, Jin L, Bridging the NFAT and NF-kappaB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress. Immunity 2001;15:47-58
   PubMed Web of Science ®Google Scholar
• Miyakawa H, Woo SK, Dahl SC, Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc Natl Acad Sci USA 1999;96:2538-42
   PubMed Web of Science ®Google Scholar
• Ko BC, Lam AK, Kapus A, Fyn and p38 signaling are both required for maximal hypertonic activation of the osmotic response element-binding protein/tonicity-responsive enhancer-binding protein (OREBP/TonEBP). J Biol Chem 2002;277:46085-92
   PubMed Web of Science ®Google Scholar
• Ferrais JD, Persaud P, Williams CK, cAMP-independent role of PKA in tonicity-induced transactivation of tonicity-responsive enhancer/osmotic response element-binding protein. Proc Natl Acad Sci USA 2002;99:16800-5
   PubMed Web of Science ®Google Scholar
• Irarrazabal CE, Liu JC, Burg MB, Ferraris JD. ATM, a DNA damage-inducible kinase, contributes to activation by high NaCl of the transcription factor TonEBP/OREBP. Proc Natl Acad Sci USA 2004;101:8809-14
   PubMed Web of Science ®Google Scholar
• Lee SD, Woo SK, Kwon HM. Dimerization is required for phosphorylation and DNA binding of TonEBP/NFAT5. Biochem Biophys Res Commun 2002;294:968-75
   PubMed Web of Science ®Google Scholar
• Tong EH, Guo KK, Huang AL, Regulation of nucleocytoplasmic trafficking of transcription factor OREBP/TonEBP/NFAT5. J Biol Chem 2006;81:23870-9
   Google Scholar
• Maouyo D, Kim JY, Lee SD, Mouse TonEBP-NFAT5: expression in early development and alternative splicing. Am J Physiol Renal Physiol 2002;282:F802-809
   PubMed Web of Science ®Google Scholar
• Trama J, Lu Q, Hawley RG, Ho SN. The NFAT-related proteinNFATL1 (TonEBP/NFAT5) is induced upon T cell activation in a calcineurin-dependent manner. J Immunol 2000;165:4884-94
   PubMed Web of Science ®Google Scholar
• Navarro P, Chiong M, Volkwein K, Osmotically-induced genes are controlled by the transcription factor TonEBP in cultured cardiomyocytes. Biochem Biophys Res Commun 2008;372:326-30
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim M, Im YS, NFAT5 induction and its role in hyperosmolar stressed human limbal epithelial cells. Invest Ophthalmol Vis Sci 2008;49:1827-35
   PubMed Web of Science ®Google Scholar
• Morancho B, Minguillon J, Molkentin JD, Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice. BMC Mol Biol 2008;9:13
   PubMedGoogle Scholar
• Ito T, Asakura K, Tougou K, Regulation of cytochrome P450 2E1 under hypertonic environment through TonEBP in human hepatocytes. Mol Pharmacol 2007;72:173-81
   PubMed Web of Science ®Google Scholar
• Aramburu J, Drews-Elger K, Estrada-Gelonch A, Regulation of the hypertonic stress response and other cellular functions by the Rel-like transcription factor NFAT5. Biochem Pharmacol 2006;72:1597-604
   PubMedGoogle Scholar
• Strolin Benedetti M, Whomsley R, Baltes EL. Differences in absorption, distribution, metabolism, and excretion of xenobiotics between the paediatric and adult populations. Expert Opin Drug Metab Toxicol 2005;1:446-71
   Google Scholar
• Kong F, Singh RP. Disintegration of solid foods in human stomach. J Food Sci 2008;73:R67-80
   PubMed Web of Science ®Google Scholar
• Kalantzi L, Goumas K, Kalioras V, Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm Res 2006;23:165-76
   PubMed Web of Science ®Google Scholar
• Gisolfi CV, Summers RW, Lambert GP, Xia T. Effect of beverage osmolality on intestinal fluid absorption during exercise. J Appl Physiol 1998;85:1941-8
   PubMed Web of Science ®Google Scholar
• Lindahl A, Ungel AL, Knutson L, Lennernas H. Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm Res 1997;14:497-502
   PubMed Web of Science ®Google Scholar
• Kalantzi L, Persson E, Polentarutti B, Canine intestinal contents vs. stimulated media for the assessment of solubility of two weak bases in the human small intestinal contents. Pharm Res 2006;23:1373-81
   PubMed Web of Science ®Google Scholar
• Pihl L, Wilander E, Nylander O. Comparative study of the effects of luminal hypotonicity on mucosal permeability in rat upper gastrointestinal tract. Acta Physiol (Oxf) 2008;193:67-78
   PubMed Web of Science ®Google Scholar
• Hoffmann ML, DenBleyker M, Smith JC, Stricker EM. Inhibition of thirst when dehydrated rats drink water or saline. Am J Physiol Regul Integr Comp Physiol 2006;290:R1199-1207
   PubMed Web of Science ®Google Scholar
• Nishinaka D, Kishino F, Matuura A. Water and electrolyte absorption from hypotonic oral rehydration solution in rat small intestine and colon. Pediatr Int 2004;46:315-21
   PubMed Web of Science ®Google Scholar
• Bachmann O, Riederer B, Rossmann H, The Na+/H+ exchanger isoform 2 is the predominant NHE isoform in murine colonic crypts and its lack causes NHE3 upregulation. Am J Physiol Gastrointest Liver Physiol 2004;287:G125-133
   PubMed Web of Science ®Google Scholar
• Mignen O, Le Gall C, Harvey BJ, Thomas S. Volume regulation following hypotonic shock in isolated crypts of mouse distal colon. J Physiol 1999;515:501-10
   PubMed Web of Science ®Google Scholar
• Osaka T, Kobayashi A, Inoue S. Therogenesis induced by osmotic stimulation of the intestines in the rat. J Physiol 2001;532:261-9
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis G, de Kanter R. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine. Drug Metab Dispos 2006;34:1047-54
   PubMed Web of Science ®Google Scholar
• Nelson DR, Zeldin DC, Hoffman SM, Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 2004;14:1-18
   PubMedGoogle Scholar
• Komura H, Iwaki M. Species differences in in vitro and in vivo small intestinal metabolism of CYP3A substrates. J Pharm Sci 2008;97:1775-800
   PubMed Web of Science ®Google Scholar
• Williams ET, Rodin AS, Strobel HW. Defining relationships between the known members of the cytochrome P450 3A subfamily, including five putative chimpanzee members. Mol Phylogenet Evol 2004;33:300-8
   PubMed Web of Science ®Google Scholar
• Darbar D, Dell'Orto S, Mörike K, Dietary salt increases first-pass elimination of oral quinidine. Clin Pharmacol Ther 1997;61:292-300
   PubMed Web of Science ®Google Scholar
• Brain WR, Sari MA, Iwasaki M, Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae. Biochemistry 1990;29:11280-92
   PubMed Web of Science ®Google Scholar
• Caporaso NE, Shaw GL. Clinical implications of the competitive inhibition of the debrisoquin-metabolizing isozyme by quinidine. Arch Intern Med 1991;151:1985-92
   PubMed Web of Science ®Google Scholar
• Darbar D, Fromm MF, Dell'Orto S, Modulation by dietary salt of verapamil disposition in humans. Circulation 1998;98:2702-8
   PubMed Web of Science ®Google Scholar
• Tracy TS, Korzekwa KR, Gonzalez FJ, Wainer W. Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil. Br J Clin Pharmacol 1999;47:545-52
   PubMed Web of Science ®Google Scholar
• Kang HJ, Song IS, Lee SS, Effects of dietary salt on the expression of drug transporters cytochrome P4503a, and nuclear receptors in rats. Xenobiotica 2008;38:147-55
   PubMed Web of Science ®Google Scholar
• Takara K, Ohnishi N, Horibe S, Yokoyama T. Expression profiles of drug-metabolizing enzymes CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNA in rat small intestine. Drug Metab Dispos 2003;31:1253-39
   Google Scholar
• Liu J, Callahan SM, Brunner LJ. Effects of sodium alternations on hepatic cytochrome P450 3A2 and 2C11 and renal function in rats. Drug Dev Ind Pharm 2003;29:767-75
   PubMed Web of Science ®Google Scholar
• Kuehl P, Zhang J, Lin Y, Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A expression. Nat Genet 2001;27:383-91
   PubMed Web of Science ®Google Scholar
• Fujita T. Aldosterone in salt-sensitive hypertension and metabolic syndrome. J Mol Med 2008;86:729-34
   PubMed Web of Science ®Google Scholar
• Biller BM, Grossman AB, Steward PM, Treatment of adrenocorticotrophin-dependent Cushing's syndrome: a consensus statement. J Clinc Endocrinol Metab 2008;93:2454-62
   PubMed Web of Science ®Google Scholar
• Haehner BD, Gorski JC, Vandenbranden M, Bimodal distribution of renal cytochrome P450 3A activity in humans. Mol Pharmacol 1996;50:52-9
   PubMed Web of Science ®Google Scholar
• Ghosh S, Grogan WM, Basu A, Watlington C. Renal corticosterone 6 beta-hydroxylase in the spontaneously hypertensive rat. Biochim Biophys Acta 1993;1182:152-6
   PubMed Web of Science ®Google Scholar
• Whiteworth JA, Williamson PM, Mangos G, Kelly JJ. Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag 2005;1:291-9
   PubMedGoogle Scholar
• Grogan WM, Philips VM, Schuetz EG, Corticosterone 6 beta-hydroxylase in A6 epithelia: a steroid-inducible cytochrome P-450. Am J Physiol. 1990;258:C480-8
   PubMed Web of Science ®Google Scholar
• Duncan RL, Grogan WM, Kramer LB, Watlington CO. Corticosterone's metabolite is an agonist for Na+ transport stimulation in A6 cells. Am J Physiol 1998;255:F736-48
   Google Scholar
• Galteau MM, Shamsa F. Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals. Eur J Clin Pharmacol 2003;59:713-33
   PubMed Web of Science ®Google Scholar
• Thompson EE, Kuttab-Boulos H, Witonsky D, CYP3A variation and the evolution of salt-sensitivity variants. Am J Hum Genet 2004;75:1059-69
   PubMed Web of Science ®Google Scholar
• Busi F, Cresteil T. CYP3A5 mRNA degradation by nonsense-mediated mRNA decay. Mol Pharmacol 2005;68:808-15
   PubMed Web of Science ®Google Scholar
• Givens RC, Lin YS, Dowling AL, CYP3A5 genotype predicts renal CYP3A activity and blood pressure in health adults. J Appl Physiol 2003;95:1297-300
   PubMed Web of Science ®Google Scholar
• Thompson EE, Kuttab-Boulous H, Yang L, Sequence diversity and haplotype structure at the human CYP3A cluster. Pharmacogenomics J 2006;6:105-14
   PubMed Web of Science ®Google Scholar
• Bochud M, Eap CB, Elston RC, Association of CYP3A5 genotypes with blood pressure and renal function in African families. J Hypertens 2006;24:923-9
   PubMed Web of Science ®Google Scholar
• Cheung C, Yu AM, Cheng CS, Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice. J Pharmacol Exp Ther 2006;316:1328-34
   PubMed Web of Science ®Google Scholar